Company Profile
Nutriband Stock Price, News & Catalysts
- Ticker:
- NTRB
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
7.36 USD (-2.13%)
Close
Last updated: October 1, 2026
43.2M USD
Market cap
Why the stock is moving
The latest monitored company update is “Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders.” The corresponding closing-price reaction is not yet available.
Company overview
Transdermal Pharmaceutical Company
Nutriband develops transdermal products and provides contract manufacturing services. Its strategy combines near-term manufacturing revenue with proprietary abuse-deterrent patch technology.
AVERSA Abuse-Deterrent Platform
AVERSA incorporates aversive agents into transdermal systems to discourage chewing, extraction, or other misuse. The platform is designed for potent drugs that benefit from continuous delivery but carry abuse risk.
AVERSA Fentanyl
The lead proprietary program applies AVERSA technology to a fentanyl patch. Nutriband is developing the product through the 505(b)(2) pathway with the goal of retaining analgesic delivery while adding abuse deterrence.
Contract Manufacturing Operations
Through Pocono Pharmaceutical, the company develops and manufactures topical and transdermal products for third parties. Services include formulation, coating, converting, packaging, and production of consumer and pharmaceutical patches.
Partner-Supported Development
Nutriband works with external manufacturers, development specialists, and regulatory advisers, including Kindeva for AVERSA Fentanyl. This model gives the company access to commercial-scale transdermal expertise without building every capability internally.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Nutriband (NTRB)?
Nutriband (NTRB) most recently closed at 7.36 USD, a -2.13% move versus the previous session.
What is the market cap of Nutriband (NTRB)?
Nutriband currently has a market capitalization of 43.2M USD on BioPharmSignal.
What does Nutriband do?
Transdermal Pharmaceutical Company Nutriband develops transdermal products and provides contract manufacturing services. Its strategy combines near-term manufacturing revenue with proprietary abuse-deterrent patch technology. AVERSA Abuse-Deterrent Platform AVERSA incorporates aversive agents into transdermal systems to discourage chewing, extraction, or...
On which exchange is NTRB stock listed?
Nutriband (NTRB) is associated with NASDAQ, United States, Biopharma.
What is Transdermal?
Transdermal Pharmaceutical Company Nutriband develops transdermal products and provides contract manufacturing services.
Which conditions is Nutriband targeting with Transdermal?
Transdermal Pharmaceutical Company Nutriband develops transdermal products and provides contract manufacturing services. Its strategy combines near-term manufacturing revenue with proprietary abuse-deterrent patch technology. AVERSA Abuse-Deterrent Platform AVERSA incorporates aversive agents into transdermal systems to discourage chewing, extraction, or...
What is Pharmaceutical?
Transdermal Pharmaceutical Company Nutriband develops transdermal products and provides contract manufacturing services.
What is Nutriband?
Transdermal Pharmaceutical Company Nutriband develops transdermal products and provides contract manufacturing services.